Inspiring Women SUMMER 2020
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
For example, four years of direct experience with patients has given me a patient-focused view<br />
that serves me well as a researcher and my BScPT degree helped me get jobs.<br />
After my PhD and post-doc, I became a faculty professor at McGill University Medical School in<br />
Montreal (where I was hired because of my PT background as I taught PT/OT students). I did that<br />
for five years, and then, because life is an adventure, I resigned and accepted a position as<br />
Director of Education for the Muscular Dystrophy Association of France. I had applied for a<br />
trans-European position that required English, but the head of the French association wanted<br />
me full time (again having a PT background was desired). That period of my life showed me<br />
how tough I was – I moved to Paris and had to adjust to a very different culture, I had to learn<br />
and work in a new language and deal with some serious health issues. My job was designing<br />
education programs for doctors, scientists, our employees and the families of kids with muscular<br />
dystrophy. It was a wonderful experience, and I will always love Paris.<br />
When I left Paris and moved back to Canada, I became a professor at the University of Ottawa<br />
as I really missed research science. My PT<br />
background was again essential – they<br />
were looking for someone with a physio<br />
undergrad, a PhD and who was French-<br />
English bilingual – I was likely the only<br />
applicant meeting those criteria.<br />
During this phase of my academic career<br />
I founded a biotech company out of my<br />
research and after five years I quit my<br />
academic position to join the company<br />
(Coley Pharmaceutical Group) full time.<br />
Eventually Pfizer bought Coley and that is<br />
how I became an employee in the “big<br />
pharma” industry. I ran the only Pfizer<br />
research and development (R&D) site in<br />
Canada but also had a global role,<br />
where I met so many brilliant people and<br />
learned so much. After eight years, my<br />
site was closed and I moved on to a role<br />
with Seqirus, a UK-headquartered flu<br />
vaccine company that spent a lot of time<br />
talking about pandemics. After three One of my paintings<br />
challenging and rewarding years with<br />
Seqirus, I took a role at Johnson &<br />
Johnson in Belgium. I lead R&D efforts related to hepatitis, which allows me to use all my<br />
learning from past jobs. It is very interesting, because it is so scientifically challenging, but also<br />
very rewarding to know that we have an opportunity to impact the lives of the nearly 300 million<br />
people in the world who are chronically infected with hepatitis B, and who face stigma every<br />
day as well as serious health outcomes later in life because of that.<br />
Today I live with my partner Mark, who is a retired fire-fighter. He has been incredibly supportive<br />
of me in my career, taking care of most day-to-day responsibilities, allowing me the time I need<br />
to devote to my job. He follows the stock market, restores and rides moto-cross bikes and was<br />
once a high-level moto-cross racer and down-hill ski racer (they say opposites attract – I am not<br />
into speed and physical danger but am much better at taking business risks). We have a 10-<br />
year old Aussie-Doodle named Oscar who has moved with us from Canada to the UK and now<br />
to Belgium. He is a high-energy but loving fellow who gives us great pleasure and keeps us busy<br />
trying to keep him busy.<br />
What was the first step you took to get involved in the COVID-19 response? As an infectious<br />
disease expert, I was mentally involved with COVID-19 right from my awareness of the first cases<br />
in China – I was fascinated and obsessed by what I was seeing. From my armchair position, I<br />
was predicting everything that was going to happen, and sadly I was right about most of it.<br />
25